The long non-coding RNA SAMMSON is essential for uveal melanoma cell survival
Open Access
- 10 September 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Oncogene
- Vol. 41 (1), 15-25
- https://doi.org/10.1038/s41388-021-02006-x
Abstract
Long non-coding RNAs (lncRNAs) can exhibit cell-type and cancer-type specific expression profiles, making them highly attractive as therapeutic targets. Pan-cancer RNA sequencing data revealed broad expression of the SAMMSON lncRNA in uveal melanoma (UM), the most common primary intraocular malignancy in adults. Currently, there are no effective treatments for UM patients with metastatic disease, resulting in a median survival time of 6–12 months. We aimed to investigate the therapeutic potential of SAMMSON inhibition in UM. Antisense oligonucleotide (ASO)-mediated SAMMSON inhibition impaired the growth and viability of a genetically diverse panel of uveal melanoma cell lines. These effects were accompanied by an induction of apoptosis and were recapitulated in two uveal melanoma patient derived xenograft (PDX) models through subcutaneous ASO delivery. SAMMSON pulldown revealed several candidate interaction partners, including various proteins involved in mitochondrial translation. Consequently, inhibition of SAMMSON impaired global, mitochondrial and cytosolic protein translation levels and mitochondrial function in uveal melanoma cells. The present study demonstrates that SAMMSON expression is essential for uveal melanoma cell survival. ASO-mediated silencing of SAMMSON may provide an effective treatment strategy to treat primary and metastatic uveal melanoma patients.Keywords
Funding Information
- Fund for Scientific Research Flanders (FWO) Standup Against Cancer (Kom op tegen Kanker) Industrial Research Grant
- Melanoma Research Alliance (MRA) Amanda and Jonathan Eilian young investigator award
This publication has 51 references indexed in Scilit:
- BAP1 deficiency causes loss of melanocytic cell identity in uveal melanomaBMC Cancer, 2013
- Elevated cyclin B2 expression in invasive breast carcinoma is associated with unfavorable clinical outcomeBMC Cancer, 2013
- Uveal MelanomaJournal of Skin Cancer, 2011
- Frequent Mutation of BAP1 in Metastasizing Uveal MelanomasScience, 2010
- SUnSET, a nonradioactive method to monitor protein synthesisNature Methods, 2009
- Frequent somatic mutations of GNAQ in uveal melanoma and blue naeviNature, 2008
- In-vivo xenograft murine human uveal melanoma model develops hepatic micrometastasesMelanoma Research, 2008
- Molecular Pathways Mediating Liver Metastasis in Patients with Uveal MelanomaClinical Cancer Research, 2008
- Tigecycline: A New Glycylcycline for Treatment of Serious InfectionsClinical Infectious Diseases, 2005
- Establishment and characterization of an uveal‐melanoma cell lineInternational Journal of Cancer, 1995